CORDIS - Forschungsergebnisse der EU
CORDIS

Bivalent hantavirus vaccine for europe: different approaches and evaluation in animal models

Ziel

Hantaviruses are health threatening infectious agents causing hemorrhagic fevers with renal syndrome in humans. In Europe, the hantaviruses Pamela and Do Brava have been identified as the main pathogens. There is an urgent need for a development of a bivalent vaccine protecting occupational risk groups and inhabitants of hyper endemic regions against infections by these two viruses.

Aufforderung zur Vorschlagseinreichung

Data not available

Koordinator

HUMBOLDT-UNIVERSITAET BERLIN
EU-Beitrag
Keine Daten
Adresse
Schumannstraße 20/21
10117 Berlin
Deutschland

Auf der Karte ansehen

Gesamtkosten
Keine Daten

Beteiligte (4)